A shear-thinning and dissolvable hydrogel
A biocompatible shear-thinning hydrogel that can be injected through needles, catheters, or microcatheters and can be dissolved on demand.
Technology No. 2023-054
IP Status: PCT Pending
Proof of concept demonstrated
Applications
- Embolic agents
- Bio-inks for 3D bioprinting
- Tissue engineering
- Drug delivery systems
Technology Overview
Embolization procedures stop blood flow to a specific blood vessel. Currently, there are no embolic agents that are rapidly dissolvable, and most of the embolic agents are not retrievable. If an off-target embolization happens, it is not reversible, and the organ will die. Researchers at the University of Minnesota have developed a novel biocompatible shear-thinning hydrogel that can be injected through needles, catheters, and microcatheters and can be dissolved on demand using an aqueous solution.
Phase of Development
TRL: 3Proof of concept demonstrated
Desired Partnerships
This technology is now available for:- License
- Sponsored research
- Co-development
Please contact our office to share your business’ needs and learn more.
Researchers
- Jafar Golzarian, MD Professor, Department of Radiology